China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Alogliptin plus Low-Dose Pioglitazone for T2DM with MASLD'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134728
Registration Time: 2026/10/20
Type: Interventional study
Primary Sponsor: Shanghai Traditional Chinese Medicine Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348441
Published by HT Digital Content Services with permission from Health Daily Digest....